3,3',5,7-tetrahydroxy-4'-methoxy-7-[2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside]Flavanone

Catalog No. :
ACQYAY268
CAS No. :
28383-41-7
Molecular Formula :
C28H34O16
Molecular Weight :
626.56

IUPAC Name:(2R,3R)-7-(((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3,5-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one

3,3',5,7-tetrahydroxy-4'-methoxy-7-[2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside]Flavanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,3',5,7-tetrahydroxy-4'-methoxy-7-[2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside]Flavanone
IUPAC Name(2R,3R)-7-(((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3,5-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one
Molecular FormulaC28H34O16
Molecular Weight626.56
SMILESO=C1[C@H](O)[C@@H](C2=CC=C(OC)C(O)=C2)OC3=C1C(O)=CC(O[C@H]4[C@H](O[C@H]5[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O5)[C@@H](O)[C@H](O)[C@@H](CO)O4)=C3
InChI KeyOWOPLXKZQIHNFD-KURXTFFSSA-N
Synonym7-Neohesperidosides;Flavanone, 3,3',5,7-tetrahydroxy-4'-methoxy-, 7-[2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside] (8CI)
CAS No.28383-41-7

Synthetic Route by SureRoute

1. ACQYAY268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQYAY268 route product structure diagram
    ACQYAY26828383-41-7
Inquiry

2. ACQYAY268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQYAY268 route product structure diagram
    ACQYAY26828383-41-7
Inquiry

Comments (0)